LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
ClosedPublished 18 Jul 2022

Ultragenyx Pharmaceutical Inc. /
GeneTx Biotherapeutics LLC

Ultragenyx Pharmaceutical acquires GeneTx Biotherapeutics

Price
$75.0m
Stage
Closed
Source · 18 Jul 2022
See the source
01 / BuyerUltragenyx Pharmaceutical Inc.
02 / TargetGeneTx Biotherapeutics LLC
01

What happened

Ultragenyx Pharmaceutical Inc. purchased all outstanding units of GeneTx Biotherapeutics LLC, making GeneTx a wholly owned subsidiary. The transaction closed on July 15, 2022.

The purchase price was $75.0 million in cash, subject to customary adjustments. Additional milestone payments may be made based on regulatory events and product sales.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Ultragenyx Pharmaceutical acquires GeneTx Biotherapeutics

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.